Analisi di costo-utilità di evolocumab in pazienti con ASCVD in Italia.

Saved in:
Bibliographic Details
Transliterated Title: Analisi di costo-utilità di evolocumab in pazienti con ASCVD in Italia.
Authors: Marcellusi A; Faculty of Economics, Economic Evaluation and HTA (EEHTA), CEIS, University of Rome 'Tor Vergata', Rome - Italy.; Institute for Leadership and Management in Health - Kingston University London, London - UK., Bini C; Faculty of Economics, Economic Evaluation and HTA (EEHTA), CEIS, University of Rome 'Tor Vergata', Rome - Italy., Rotundo MA; Faculty of Economics, Economic Evaluation and HTA (EEHTA), CEIS, University of Rome 'Tor Vergata', Rome - Italy., Arcangeli E; Value & Access Department Italy, Amgen Srl, Milan - Italy., Martinez L; AMGEN Europe, Rotkreuz - Switzerland., Vilela FS; AMGEN Europe, Rotkreuz - Switzerland., Mennini FS; Faculty of Economics, Economic Evaluation and HTA (EEHTA), CEIS, University of Rome 'Tor Vergata', Rome - Italy.; Institute for Leadership and Management in Health - Kingston University London, London - UK.
Source: Global & regional health technology assessment [Glob Reg Health Technol Assess] 2021 Nov 02; Vol. 8, pp. 155-167. Date of Electronic Publication: 2021 Nov 02 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: AboutScience Country of Publication: Italy NLM ID: 9918417986506676 Publication Model: eCollection Cited Medium: Internet ISSN: 2283-5733 (Electronic) Linking ISSN: 22842403 NLM ISO Abbreviation: Glob Reg Health Technol Assess Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2283-5733
DOI:10.33393/grhta.2021.2255